Extended Access of Momelotinib for Subjects with Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (POST-PV/ET MF)

  • Perkins, Andrew (Primary Chief Investigator (PCI))
  • Ross, David Morrall (Chief Investigator (CI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date5/05/21 → 31/12/24

Keywords

  • Primary Myelofibrosis
  • blood disorders
  • Clinical trial